Cineline India (CINELINE)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter is profitable: ₹67 Cr sales and ₹6 Cr net profit
• Piotroski F-Score of 7/9 indicates improving financial health
• Promoter holding at 69.6% aligns management with shareholders
• P/E of 13.70 is not demanding if earnings prove sustainable
• Debt/equity of 0.71 is manageable for a capital-intensive business

Concerns

• ROE of -25.59% shows poor recent shareholder capital efficiency
• ROCE of only 5.25% is weak and likely below an acceptable cost of capital
• Zero dividend yield means minority shareholders get no cash return
• PEG of 0.06 is misleading because 491% profit growth comes off a low, distressed base

AI Analysis

Walking through Cineline India's numbers, I feel the same caution as when I see a business that has burned capital recently. ROE is -25.59%, a serious black mark; book value per share is ₹53.84, but the market prices the stock at ₹89.03, or 1.65 times book. That valuation assumes the worst is over. The latest quarter—sales ₹67 Cr and net profit ₹6 Cr—shows a pulse, and the 491% profit growth explains the low reported P/E of 13.70, but I don't trust a profit explosion off a low base. Sales growth is only 6.16%, so the earnings jump is mostly margin recovery, not durable demand compounding. The Piotroski score of 7/9 does encourage me; it suggests improving fundamentals, and promoter holding of 69.6% aligns owners with shareholders. But the balance sheet is not fortress-like: debt-to-equity is 0.71 and ROCE is just 5.25%. In a capital-intensive exhibition business, I need returns well above borrowing costs, and I don't see that yet. Dividend yield is nil; as a minority investor, I'm relying entirely on capital appreciation. Some call this cheap because PEG is 0.06. That is nonsense—PEG is only meaningful with stable, high-quality growth. This is not a Stalwart; this is a turnaround. At ₹89.03, the market is paying for successful recovery. I would want proof: sustained quarterly profits, rising ROCE, and debt reduction. If the business can generate healthy returns on capital, the current valuation might be reasonable. Until then, I'd rather watch than commit.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer